F. Huguet

745 total citations
13 papers, 527 citations indexed

About

F. Huguet is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, F. Huguet has authored 13 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in F. Huguet's work include Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Cancer therapeutics and mechanisms (3 papers). F. Huguet is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Cancer therapeutics and mechanisms (3 papers). F. Huguet collaborates with scholars based in France, United States and Italy. F. Huguet's co-authors include A.M. Peny, Bruno Anglaret, Thierry Façon, B. Grosbois, Jean‐Luc Harousseau, Philippe Rodon, A. Azzedine, Christian Berthou, Michel Attal and J Pris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Haematologica.

In The Last Decade

F. Huguet

13 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Huguet France	9	319	199	172	137	90	13	527
R Battista Italy	14	278 0.9×	282 1.4×	141 0.8×	91 0.7×	142 1.6×	42	581
Per Bernell Sweden	15	336 1.1×	190 1.0×	97 0.6×	133 1.0×	71 0.8×	27	523
Yves Devaux France	11	211 0.7×	96 0.5×	173 1.0×	86 0.6×	109 1.2×	31	457
E. P. Alessandrino Italy	11	345 1.1×	96 0.5×	120 0.7×	115 0.8×	118 1.3×	26	505
Susan R. Wiersma United States	13	260 0.8×	175 0.9×	78 0.5×	137 1.0×	54 0.6×	16	517
Eva Hoke United States	14	390 1.2×	239 1.2×	231 1.3×	183 1.3×	158 1.8×	22	662
Guru Subramanian Guru Murthy United States	13	338 1.1×	114 0.6×	160 0.9×	137 1.0×	85 0.9×	81	520
KG Blume United States	10	486 1.5×	167 0.8×	271 1.6×	88 0.6×	62 0.7×	15	687
Olga Militano United States	12	247 0.8×	134 0.7×	176 1.0×	55 0.4×	65 0.7×	42	446
P. Y. Leprise France	7	143 0.4×	173 0.9×	358 2.1×	172 1.3×	153 1.7×	8	575

Countries citing papers authored by F. Huguet

Since Specialization

Citations

This map shows the geographic impact of F. Huguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Huguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Huguet more than expected).

Fields of papers citing papers by F. Huguet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Huguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Huguet. The network helps show where F. Huguet may publish in the future.

Co-authorship network of co-authors of F. Huguet

This figure shows the co-authorship network connecting the top 25 collaborators of F. Huguet. A scholar is included among the top collaborators of F. Huguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Huguet. F. Huguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rizzieri, David A., Utz Krug, R. Schlenk, et al.. (2011). A phase II study of elacytarabine plus idarubicin as second course remission-induction therapy in patients with acute myeloid leukemia.. Journal of Clinical Oncology. 29(15_suppl). TPS207–TPS207. 3 indexed citations

Gökbuget, Nicola, Renato Bassan, Hans Guenter Derigs, et al.. (2010). Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma. Haematologica. 96(2). 238–244. 44 indexed citations

Huguet, F., Thibaut Leguay, Francis Lacombe, et al.. (2009). Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. Haematologica. 95(2). 324–328. 71 indexed citations

Pigneux, Arnaud, Éric Jourdan, Norbert Vey, et al.. (2007). Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results. Haematologica. 92(10). 1327–1334. 26 indexed citations

Façon, Thierry, Jean‐Luc Harousseau, F. Huguet, et al.. (2006). Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 1–1. 148 indexed citations

Dhédin, Nathalie, Xavier Thomas, F. Huguet, et al.. (2002). No Superiority of Autologous Stem Cell Transplantation over Chemotherapy Alone in Adult Ph-Negative ALL in First Complete Remission A Long Follow-Up Report Combining Results of LALA 85, 87 and 94 Trials. Blood. 100(11). 81516. 2 indexed citations

Reiffers, Josy, F. Huguet, Anne Marie Stoppa, et al.. (1996). A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.. PubMed. 10(3). 389–95. 65 indexed citations

Reiffers, Josy, Anne Marie Stoppa, Michel Attal, et al.. (1996). Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study.. PubMed. 10(12). 1874–82. 86 indexed citations

Attal, Michel, Pierre Canal, D Schlaifer, et al.. (1994). Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.. Journal of Clinical Oncology. 12(1). 141–148. 30 indexed citations

10.

Rubie, Hervé, Laurence Gladieff, Alain Robert, et al.. (1994). Childhood anaplastic large cell lymphoma Ki‐1/CD30: Clinicopathologic features of 19 cases. Medical and Pediatric Oncology. 22(3). 155–161. 26 indexed citations

11.

Schlaifer, D, Michel Attal, F. Huguet, et al.. (1994). Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation.. PubMed. 31(2 Suppl 3). 31–31. 8 indexed citations

12.

Reiffers, Josy, Anne Marie Stoppa, Michel Attal, et al.. (1993). Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience.. PubMed. 35(1). 17–9. 14 indexed citations

13.

Rubie, H, Michel Attal, J Lemozy, et al.. (1988). [Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].. PubMed. 36(7). 912–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact